Clinical Trials Directory

Trials / Unknown

UnknownNCT05329389

Adherence to Fluid Intake Recommendations in Kidney Stone Patients

Adherence to Fluid Intake Recommendations After Stone Removal in Low Risk Group Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
135 (estimated)
Sponsor
Gadzhiev Nariman · Academic / Other
Sex
All
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The cumulative risk of stone recurrence rate is up to 14% at 1 year, 35% at 5 years, and 52% at 10 years. Low urine volume caused by insufficient fluid consumption is one of the most crucial risk factors for kidney stone formation. According to the guidelines, a copious fluid intake to maintain a urine volume of at least 2.0 to 2.5 L/24 h is recommended for most kidney stone formers. Patients often find it difficult to follow the recommendations in fluid intake, which leads to stone recurrence. Therefore, there is a need to improve patient compliance and adherence to following the instructions on keeping water balance. For this purpose we developed a mixed educational program including two parts. The first is the mobile application called "StoneMD: Kidney Stones". The second is the "School for Patients" with kidney stones, which is responsible for the stone clinic effect.

Detailed description

The aim of the study is to test the hypothesis that using mixed educational program additionally to standard recommendations in patients after the first stone surgery episode helps to achieve better adherence to daily fluid intake recommendations than the using standard recommendations alone given at the day of discharge.

Conditions

Interventions

TypeNameDescription
DEVICEStoneMDStoneMD - is an app from App Store (for iOS) or Google Play (for Android).
BEHAVIORALSchools of PatientsThe "Schools for Patients" with Urolithiasis is an online course for patients with urinary stone disease.
BEHAVIORALStandard recommendationOnly fluid balance recommendations given at the day of discharge.

Timeline

Start date
2023-01-01
Primary completion
2024-04-04
Completion
2024-07-01
First posted
2022-04-15
Last updated
2023-05-09

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05329389. Inclusion in this directory is not an endorsement.